Today: 21 April 2026
Subscribe
Browse Category

NASDAQ:AGH 9 March 2026

Aureus Greenway Holdings to Buy Powerus in Drone Pivot, With $9 Million Raise

Aureus Greenway Holdings to Buy Powerus in Drone Pivot, With $9 Million Raise

Aureus Greenway Holdings will acquire drone maker Powerus in an all-stock deal to take it public, renaming the combined company Powerus Corp and targeting a summer 2026 Nasdaq listing as PUSA. South Korea's KCGI committed to buy $50 million in Powerus stock, while Aureus arranged $9 million in new financing. The deal still requires SEC and shareholder approval. AGH shares rose 12.8% in premarket trading.
9 March 2026
·

Stock Market Today

  • Specialized Chipmakers Like Navitas Benefit from Rising AI and EV Power Needs
    April 21, 2026, 11:15 AM EDT. Specialized semiconductor firms, such as Navitas Semiconductor, are gaining attention amid surging demand for power-efficient chips. Navitas focuses on silicon carbide and gallium nitride materials, which offer greater energy efficiency and durability than traditional silicon. These chips are increasingly used in electric vehicle (EV) chargers, mobile devices, solar systems, and data centers handling artificial intelligence (AI) workloads. AI processors consume far more power than standard chips, pushing data center electricity use in the U.S. higher, coinciding with rising national electricity costs. Improved power management technology is becoming essential. Navitas recently introduced a power converter for data centers that achieves high efficiency, positioning the company well within a market dominated by major semiconductor firms like Intel, NVIDIA, and AMD.

Latest article

Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

21 April 2026
Eli Lilly will acquire Boston-based Kelonia Therapeutics for up to $7 billion in cash, including $3.25 billion upfront, to expand into in vivo CAR-T cancer therapies. Kelonia’s KLN-1010, in Phase 1 for multiple myeloma, generates engineered T-cells inside the patient. The deal marks Lilly’s third Massachusetts biotech purchase in 2026. Kelonia had 62 employees and nearly ran out of cash before the offer.
POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

21 April 2026
POET Technologies shares surged 20% Tuesday, following an 18% gain Monday, after the company addressed U.S. shareholder tax concerns and announced plans to redomicile. Nearly 32.9 million shares traded by 10:21 a.m. ET, with the stock reaching $11.07 before settling at $10.34. Wolfpack Research disclosed a short position last week, sparking volatility. CFO Thomas Mika said POET expects not to qualify as a PFIC in 2026.
Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

21 April 2026
Rocket Lab shares rose 2% to $91.12 Tuesday after analysts raised price targets and the Pentagon detailed new space defense spending in its 2027 budget request. The company closed its $155 million Mynaric acquisition last week and reported a $190 million Pentagon launch contract in March, bringing its backlog above $2 billion. Rocket Lab now expects to launch its Neutron rocket in late 2026 after a test setback.
Go toTop